Patricia A. Ganz
#62,521
Most Influential Person Now
American medical oncologist
Patricia A. Ganz's AcademicInfluence.com Rankings
Patricia A. Ganzphilosophy Degrees
Philosophy
#2886
World Rank
#4788
Historical Rank
Logic
#827
World Rank
#1376
Historical Rank
Download Badge
Philosophy
Why Is Patricia A. Ganz Influential?
(Suggest an Edit or Addition)According to Wikipedia, Patricia Anne Ganz is an American medical oncologist. She is a professor of health policy and management in the Fielding School of Public Health and a professor of medicine in the David Geffen School of Medicine at UCLA. In 2007, she was elected to the Institute of Medicine.
Patricia A. Ganz's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). (2009) (2033)
- Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. (2006) (1594)
- From cancer patient to cancer survivor : lost in transition : an American Society of Clinical Oncology and Institute of Medicine Symposium (2006) (1513)
- Karnofsky performance status revisited: reliability, validity, and guidelines. (1984) (1281)
- Delivering High-Quality Cancer Care: Charting a New Course for a System in Crisis (2014) (1100)
- Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. (2000) (1076)
- Quality of life in long-term, disease-free survivors of breast cancer: a follow-up study. (2002) (1039)
- Quality-of-life outcomes in men treated for localized prostate cancer. (1995) (1036)
- Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. (2010) (1008)
- Life after breast cancer: understanding women's health-related quality of life and sexual functioning. (1998) (945)
- The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. (1998) (824)
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline. (2016) (796)
- American Society of Clinical Oncology Statement: A Conceptual Framework to Assess the Value of Cancer Treatment Options. (2015) (722)
- Quality of life, fertility concerns, and behavioral health outcomes in younger breast cancer survivors: a systematic review. (2012) (691)
- Fatigue in long‐term breast carcinoma survivors (2006) (640)
- Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing Breast Cancer (2010) (594)
- Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. (2000) (589)
- Patterns of care related to age of breast cancer patients. (1987) (540)
- Fatigue and Proinflammatory Cytokine Activity in Breast Cancer Survivors (2002) (529)
- Quality of life at the end of primary treatment of breast cancer: first results from the moving beyond cancer randomized trial. (2004) (528)
- Arm edema in breast cancer patients. (2001) (526)
- American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. (2012) (508)
- Breast cancer in younger women: reproductive and late health effects of treatment. (2003) (503)
- Polychemotherapy in advanced non small cell lung cancer: a meta-analysis (1993) (501)
- Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation. (2014) (465)
- Health-related quality of life and tamoxifen in breast cancer prevention: a report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study. (1999) (444)
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received. (2016) (435)
- Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? (2011) (433)
- Cognitive impairment associated with chemotherapy for cancer: report of a workshop. (2004) (432)
- Breast cancer survivors: Psychosocial concerns and quality of life (2005) (429)
- Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition * (2003) (429)
- Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology. (1996) (417)
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
- Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer. (2021) (398)
- Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. (2015) (390)
- Neurocognitive Performance in Breast Cancer Survivors Exposed to Adjuvant Chemotherapy and Tamoxifen (2004) (384)
- Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5–10 years after chemotherapy (2007) (379)
- CAncer rehabilitation evaluation system–short form (CARES‐SF). A cancer specific rehabilitation and quality of life instrument (1991) (364)
- Quality of life assessment. An independent prognostic variable for survival in lung cancer (1991) (354)
- Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? (1992) (350)
- Predictors of sexual health in women after a breast cancer diagnosis. (1999) (345)
- Rapid-learning system for cancer care. (2010) (325)
- Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial. (2008) (310)
- 1st International consensus guidelines for advanced breast cancer (ABC 1). (2012) (308)
- Managing menopausal symptoms in breast cancer survivors: results of a randomized controlled trial. (2000) (305)
- Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer. (2010) (305)
- Yoga for persistent fatigue in breast cancer survivors (2012) (291)
- Quality of life in adult survivors of lung, colon and prostate cancer (1994) (289)
- Perspectives on comorbidity and cancer in older patients: approaches to expand the knowledge base. (2001) (285)
- Perceptions of positive meaning and vulnerability following breast cancer: Predictors and outcomes among long-term breast cancer survivors (2005) (285)
- American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline (2016) (284)
- Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. (2001) (281)
- Diurnal cortisol rhythm and fatigue in breast cancer survivors (2005) (278)
- Clinical cancer advances 2008: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. (2009) (277)
- Mindfulness meditation for younger breast cancer survivors: A randomized controlled trial (2015) (271)
- Inflammatory Biomarkers and Fatigue during Radiation Therapy for Breast and Prostate Cancer (2009) (266)
- The Role of Obesity in Cancer Survival and Recurrence (2012) (265)
- Characteristics of women at risk for psychosocial distress in the year after breast cancer. (1993) (263)
- Health-related quality-of-life measurement in randomized clinical trials in breast cancer--taking stock. (2003) (262)
- Psychologic distress and natural menopause: a multiethnic community study. (2001) (261)
- Breast cancer in older women: quality of life and psychosocial adjustment in the 15 months after diagnosis. (2003) (260)
- Inflammatory biomarkers for persistent fatigue in breast cancer survivors (2006) (258)
- Differences Between Primary Care Physicians’ and Oncologists’ Knowledge, Attitudes and Practices Regarding the Care of Cancer Survivors (2011) (255)
- The eight-item modified Medical Outcomes Study Social Support Survey: psychometric evaluation showed excellent performance. (2012) (252)
- Patient-reported symptoms and quality of life during treatment with tamoxifen or raloxifene for breast cancer prevention: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. (2006) (247)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery (1999) (242)
- Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. (2008) (238)
- Outcomes from the Moving Beyond Cancer psychoeducational, randomized, controlled trial with breast cancer patients. (2005) (231)
- Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial (2019) (230)
- Altered Cortisol Response to Psychologic Stress in Breast Cancer Survivors With Persistent Fatigue (2005) (228)
- Cancer survivorship: a new challenge in delivering quality cancer care. (2006) (227)
- Implementing a survivorship care plan for patients with breast cancer. (2008) (227)
- Neurotoxicity from oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: NSABP C-07. (2007) (226)
- Validity of cancer registry data for measuring the quality of breast cancer care. (2002) (226)
- Physical and psychosocial recovery in the year after primary treatment of breast cancer. (2011) (222)
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (2017) (211)
- Missing quality of life data in cancer clinical trials: serious problems and challenges. (1998) (210)
- Facets of spirituality as predictors of adjustment to cancer: relative contributions of having faith and finding meaning. (2009) (210)
- Base-line quality-of-life assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial. (1995) (208)
- Yoga reduces inflammatory signaling in fatigued breast cancer survivors: A randomized controlled trial (2014) (207)
- Impact of different adjuvant therapy strategies on quality of life in breast cancer survivors. (1998) (207)
- Survivorship: adult cancer survivors. (2009) (206)
- Quality of life of African‐American and white long term breast carcinoma survivors (1999) (206)
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (2018) (206)
- Promoting adjustment after treatment for cancer (2005) (204)
- Supportive care versus supportive care and combination chemotherapy in metastatic non‐small cell lung cancer. Does chemotherapy make a difference? (1989) (204)
- Quality of life in patients with heart failure: do gender differences exist? (2001) (198)
- Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. (2015) (197)
- Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
- Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the functional living index—cancer (1988) (193)
- Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. (2013) (189)
- Quality of Life in Diverse Groups of Midlife Women: Assessing the Influence of Menopause, Health Status and Psychosocial and Demographic Factors (2004) (180)
- A teachable moment for oncologists: cancer survivors, 10 million strong and growing! (2005) (174)
- Patient Adherence to Cancer Control Regimens: Scale Development and Initial Validation (1993) (172)
- Life after diagnosis and treatment of cancer in adulthood: contributions from psychosocial oncology research. (2015) (171)
- Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors. (2015) (168)
- Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations. (2016) (168)
- Association of Actual and Preferred Decision Roles With Patient-Reported Quality of Care: Shared Decision Making in Cancer Care. (2015) (168)
- Predicting Psychosocial Risk in Patients With Breast Cancer (1993) (168)
- The impact of cancer and quality of life for long‐term survivors (2008) (167)
- Sexuality following breast cancer. (1999) (165)
- Ensuring quality care for cancer survivors: implementing the survivorship care plan. (2008) (163)
- The BCPT symptom scales: a measure of physical symptoms for women diagnosed with or at risk for breast cancer. (2005) (159)
- The CARES: a generic measure of health-related quality of life for patients with cancer (1992) (158)
- Inflammatory responses to psychological stress in fatigued breast cancer survivors: Relationship to glucocorticoids (2007) (157)
- Psychological and social aspects of breast cancer. (2008) (157)
- Assessing the impact of cancer: development of a new instrument for long‐term survivors (2006) (155)
- Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. (2014) (154)
- Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction? (2013) (154)
- Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32. (2010) (154)
- Interventions to Address Sexual Problems in People With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Adaptation of Cancer Care Ontario Guideline. (2017) (152)
- Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer. (2010) (151)
- Survivorship care planning after the Institute of Medicine recommendations: how are we faring? (2011) (150)
- A Standard Set of Value-Based Patient-Centered Outcomes for Breast Cancer: The International Consortium for Health Outcomes Measurement (ICHOM) Initiative (2017) (149)
- Inflammatory Biomarkers for Persistent Fatigue in Breast Cancer Survivors (2006) (146)
- Sleep difficulty in women at midlife: a community survey of sleep and the menopausal transition. (2003) (145)
- Fatigue and gene expression in human leukocytes: Increased NF-κB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue (2011) (144)
- Assessing problems of cancer patients: psychometric properties of the cancer inventory of problem situations. (1990) (143)
- T-cell homeostasis in breast cancer survivors with persistent fatigue. (2003) (141)
- Sleep disturbance, inflammation and depression risk in cancer survivors (2013) (137)
- Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial (2016) (137)
- Cancer survivorship and cancer rehabilitation: revitalizing the link. (2012) (137)
- Patterns of care related to age of men with prostate cancer (1991) (136)
- Late effects of cancer and its treatment. (2001) (135)
- Patient-reported outcomes assessment in cancer trials: taking stock, moving forward. (2007) (133)
- Possible socioeconomic and ethnic disparities in quality of life in a cohort of breast cancer survivors (2007) (129)
- Cytokine gene polymorphisms and fatigue in breast cancer survivors: Early findings (2008) (128)
- Understanding cancer patients’ experience and outcomes: development and pilot study of the Cancer Care Outcomes Research and Surveillance patient survey (2006) (127)
- Clinical Cancer Advances 2005: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. (2006) (126)
- Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort (2011) (126)
- Future cancer research priorities in the USA: a Lancet Oncology Commission. (2017) (125)
- Patient-centered cancer treatment planning: improving the quality of oncology care. Summary of an Institute of Medicine workshop. (2011) (123)
- Patients' experiences with care for lung cancer and colorectal cancer: findings from the Cancer Care Outcomes Research and Surveillance Consortium. (2010) (123)
- Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. (2011) (122)
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
- Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. (2016) (121)
- National Institutes of Health State-of-the-Science Conference: Role of Active Surveillance in the Management of Men With Localized Prostate Cancer (2012) (121)
- Monitoring the physical health of cancer survivors: a survivorship-focused medical history. (2006) (120)
- Long-term prognostic role of functional limitations among women with breast cancer. (2010) (119)
- Tai chi, cellular inflammation, and transcriptome dynamics in breast cancer survivors with insomnia: a randomized controlled trial. (2014) (119)
- Assessing the quality of life--a study in newly-diagnosed breast cancer patients. (1990) (118)
- Suicide after breast cancer: an international population-based study of 723,810 women. (2006) (117)
- The Psychosocial Impact of Cancer on the Elderly: A Comparison with Younger Patients (1985) (116)
- Use of survivorship care plans in the United States: associations with survivorship care. (2013) (115)
- Living with cancer: the Cancer Inventory of Problem Situations. (1984) (114)
- Cytokine genetic variations and fatigue among patients with breast cancer. (2013) (114)
- Clinical Cancer Advances 2009: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. (2009) (113)
- National Institutes of Health State-of-the-Science Conference (2012) (113)
- The role of families in decisions regarding cancer treatments (2015) (113)
- Addressing intimacy and partner communication after breast cancer: a randomized controlled group intervention (2009) (112)
- Cancer patients' roles in treatment decisions: do characteristics of the decision influence roles? (2010) (111)
- Refinement and psychometric evaluation of the impact of cancer scale. (2008) (110)
- Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. (2006) (108)
- Effect of depression on diagnosis, treatment, and mortality of men with clinically localized prostate cancer. (2014) (106)
- Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial. (2017) (106)
- Health-related quality of life in a multiethnic sample of breast cancer survivors (2004) (105)
- Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control. (2014) (105)
- Tamoxifen and depression: more evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) Randomized Study. (2001) (105)
- Association of breast cancer and its therapy with menopause-related symptoms (2004) (105)
- Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial (2008) (104)
- Understanding the Breast Cancer Experience of African-American Women (1997) (104)
- Physician preferences and attitudes regarding different models of cancer survivorship care: a comparison of primary care providers and oncologists (2013) (104)
- Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. (2002) (102)
- The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer (2013) (101)
- Quality of Life of Breast Cancer Survivors After a Recurrence: A Follow-Up Study (2004) (101)
- Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (2011) (101)
- Going Beyond Being Lost in Transition: A Decade of Progress in Cancer Survivorship. (2017) (100)
- Cancer Inventory of Problem Situations (1993) (100)
- Implementing cancer survivorship care planning : workshop summary (2007) (100)
- Influence of exercise activity on quality of life in long-term breast cancer survivors (2005) (98)
- Exploring the influence of multiple variables on the relationship of age to quality of life in women with breast cancer. (1992) (98)
- Factors related to sexual function in postmenopausal women with a history of breast cancer (2001) (97)
- Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. (2013) (97)
- Adjuvant tamoxifen prescription in women 65 years and older with primary breast cancer. (2002) (96)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
- Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (2012) (92)
- Low heart rate variability and cancer-related fatigue in breast cancer survivors (2014) (92)
- Health status and quality of life in patients with early-stage Hodgkin's disease treated on Southwest Oncology Group Study 9133. (2003) (91)
- Long-Term Survivorship Care After Cancer Treatment - Summary of a 2017 National Cancer Policy Forum Workshop. (2018) (91)
- Breast cancer, menopause, and long-term survivorship: critical issues for the 21st century. (2005) (91)
- Why and how to study the fate of cancer survivors: observations from the clinic and the research laboratory. (2003) (90)
- Report from a National Cancer Institute (USA) workshop on quality of life assessment in cancer clinical trials (1992) (89)
- Use of β-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and risk of breast cancer recurrence: a Danish nationwide prospective cohort study. (2013) (89)
- Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial (2015) (88)
- Impact of tamoxifen adjuvant therapy on symptoms, functioning, and quality of life. (2001) (86)
- Sixty Years of CA: A Cancer Journal for Clinicians (2010) (86)
- Do survivorship care plans make a difference? A primary care provider perspective. (2011) (84)
- Cancer related fatigue: A focus on breast cancer and Hodgkin's disease survivors (2007) (83)
- Long‐term neurotoxicity effects of oxaliplatin added to fluorouracil and leucovorin as adjuvant therapy for colon cancer: Results from National Surgical Adjuvant Breast and Bowel Project trials C‐07 and LTS‐01 (2012) (83)
- The Trajectory of Psychological Impact in BRCA1/2 Genetic Testing: Does Time Heal? (2008) (83)
- Reducing breast cancer recurrence with weight loss, a vanguard trial: the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial. (2013) (83)
- Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers. (2007) (83)
- Obesity and Cardiovascular Risk Factors in Younger Breast Cancer Survivors: The Cancer and Menopause Study (CAMS) (2005) (83)
- Cancer survivorship care: don't let the perfect be the enemy of the good. (2012) (82)
- Barriers to breast and colorectal cancer survivorship care: perceptions of primary care physicians and medical oncologists in the United States. (2013) (82)
- Contextual life stress and coping strategies as predictors of adjustment to breast cancer survivorship (2006) (81)
- Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology. (2008) (79)
- Cancer survivorship : today and tomorrow (2007) (79)
- Recruitment and retention challenges in breast cancer survivorship research: results from a multisite, randomized intervention trial in women with early stage breast cancer. (2003) (78)
- Issues and challenges with integrating patient-reported outcomes in clinical trials supported by the National Cancer Institute-sponsored clinical trials networks. (2007) (77)
- Cancer-related intrusive thoughts predict behavioral symptoms following breast cancer treatment. (2014) (77)
- Young adult cancer survivors and work: a systematic review (2017) (77)
- Cognitive function after the initiation of adjuvant endocrine therapy in early-stage breast cancer: an observational cohort study. (2014) (76)
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
- Who provides psychosocial follow-up care for post-treatment cancer survivors? A survey of medical oncologists and primary care physicians. (2012) (76)
- Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897. (2008) (76)
- Post-traumatic stress symptoms in long-term non-Hodgkin's lymphoma survivors: does time heal? (2011) (76)
- A longitudinal examination of couples' coping strategies as predictors of adjustment to breast cancer. (2011) (76)
- Breast Cancer Survivorship: Where Are We Today? (2015) (76)
- Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. (2007) (75)
- Employment among survivors of lung cancer and colorectal cancer. (2010) (75)
- Primary care provider perceptions of barriers to and facilitators of colorectal cancer screening in a managed care setting (2004) (75)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
- Improvements in Emotion Regulation Following Mindfulness Meditation: Effects on Depressive Symptoms and Perceived Stress in Younger Breast Cancer Survivors (2017) (74)
- Decline in physical functioning in first 2 years after breast cancer diagnosis predicts 10-year survival in older women (2013) (73)
- Adult cancer survivorship care: experiences from the LIVESTRONG centers of excellence network (2011) (71)
- Long-term Peripheral Neuropathy in Breast Cancer Patients Treated With Adjuvant Chemotherapy: NRG Oncology/NSABP B-30 (2018) (71)
- Patterns of care in early-stage breast cancer survivors in the first year after cessation of active treatment. (2006) (71)
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (2017) (70)
- Psychosocial concerns and quality of life in breast cancer survivors. (1999) (70)
- Fatigue After Breast Cancer Treatment: Biobehavioral Predictors of Fatigue Trajectories (2018) (70)
- The impact of cancer and quality of life for post‐treatment non‐Hodgkin lymphoma survivors (2010) (69)
- Quality of Life Across the Continuum of Breast Cancer Care (2000) (68)
- Symptom management after breast cancer treatment: is it influenced by patient characteristics? (2008) (68)
- Current issues in cancer rehabilitation (1990) (67)
- Quality of life in operable colon cancer patients receiving oral compared with intravenous chemotherapy: results from National Surgical Adjuvant Breast and Bowel Project Trial C-06. (2007) (67)
- Shared heritability and functional enrichment across six solid cancers (2018) (67)
- Cancer care and cancer survivorship care in the United States: will we be able to care for these patients in the future? (2009) (67)
- The quality of life after breast cancer--solving the problem of lymphedema. (1999) (67)
- Impact of Physician–Patient Discussions on Patient Satisfaction (2008) (66)
- Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial (2016) (66)
- Impact of quality of life outcomes on clinical practice. (1995) (66)
- Cigarette Smoking, Obesity, Physical Activity, and Alcohol Use As Predictors of Chemoprevention Adherence in the National Surgical Adjuvant Breast and Bowel Project P-1 Breast Cancer Prevention Trial (2011) (65)
- Beyond the development of quality-of-life instruments: where do we go from here? (2002) (65)
- Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23 (2004) (65)
- Profile of men randomized to the prostate cancer prevention trial: baseline health-related quality of life, urinary and sexual functioning, and health behaviors. (2000) (65)
- Symbiotic relationships of quality of life, health services research and other health research (1994) (65)
- Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. (2019) (64)
- Quality of life and the patient with cancer. Individual and policy implications (1994) (64)
- Advancing survivorship care through the National Cancer Survivorship Resource Center (2013) (64)
- Delivering high-quality and affordable care throughout the cancer care continuum. (2013) (64)
- A population-based assessment of specialty physician involvement in cancer clinical trials. (2011) (64)
- Assessing the needs and quality of life of patients with HIV infection: development of theHIVOverview ofProblems-EvaluationSystem (HOPES) (1992) (63)
- Occult ovarian cancers identified at risk-reducing salpingo-oophorectomy in a prospective cohort of BRCA1/2 mutation carriers (2010) (63)
- Quality of life over 5 years after a breast cancer diagnosis among low‐income women: Effects of race/ethnicity and patient‐physician communication (2015) (63)
- Complementary and alternative therapies among very long-term breast cancer survivors (2009) (62)
- Current state of quality of life and patient-reported outcomes research. (2019) (61)
- Multilevel factors affecting quality: examples from the cancer care continuum. (2012) (61)
- Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator (2004) (61)
- Impact of Adjuvant Endocrine Therapy on Quality of Life and Symptoms: Observational Data Over 12 Months From the Mind-Body Study. (2016) (61)
- Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (2020) (60)
- Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2012) (60)
- Proposed agenda for the measurement of quality-of-care outcomes in oncology practice. (1999) (59)
- Making effective use of tumor registries for cancer survivorship research (2001) (59)
- 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1 (2012) (59)
- Older breast cancer survivors: factors associated with change in emotional well-being. (2007) (59)
- Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women (2008) (59)
- Symptoms after breast cancer treatment: are they influenced by patient characteristics? (2007) (59)
- Use of risk-reducing surgeries in a prospective cohort of 1,499 BRCA1 and BRCA2 mutation carriers (2014) (58)
- Survivorship programs and care plans in practice: variations on a theme. (2011) (58)
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
- Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. (2011) (57)
- Patient-reported outcomes assessment in cancer trials: evaluating and enhancing the payoff to decision making. (2007) (56)
- Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect? (1998) (55)
- Treatment of estrogen deficiency symptoms in women surviving breast cancer. The Hormone Foundation, Canadian Breast Cancer Research Initiative, National Cancer Institute of Canada, Endocrine Society, and the University of Virginia Cancer Center and Woman's Place. (1999) (54)
- Psychosocial issues in lung cancer patients (Part 1). (1991) (54)
- Quality of care and cancer survivorship: the challenge of implementing the institute of medicine recommendations. (2009) (54)
- Responses of patients with neoplastic diseases to influenza virus vaccine (1978) (54)
- Quality of life in advanced non-small-cell lung cancer: Results of a Southwest Oncology Group randomized trial (2002) (53)
- Patient‐centered, evidence‐based, and cost‐conscious cancer care across the continuum: Translating the Institute of Medicine report into clinical practice (2014) (53)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
- Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers (2009) (53)
- Older Breast Cancer Survivors: Factors Associated with Self‐reported Symptoms of Persistent Lymphedema Over 7 years of Follow‐up (2010) (52)
- Treatment options for breast cancer--beyond survival. (1992) (52)
- Breast Cancer Treatment and Cognitive Functioning: Current Status and Future Challenges in Assessment (2005) (52)
- Use of patient-reported outcomes in phase III cancer treatment trials: lessons learned and future directions. (2007) (52)
- Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. (2015) (52)
- Randomized Controlled Trial of Survivorship Care Plans Among Low-Income, Predominantly Latina Breast Cancer Survivors. (2017) (51)
- Quality of life among long-term survivors of non-Hodgkin lymphoma: a follow-up study. (2013) (51)
- Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. (2010) (50)
- Posttraumatic growth in breast cancer survivors: does age matter? (2017) (50)
- How confident are young adult cancer survivors in managing their survivorship care? A report from the LIVESTRONG™ Survivorship Center of Excellence Network (2011) (50)
- Barriers to physical activity and healthy eating in young breast cancer survivors: modifiable risk factors and associations with body mass index (2013) (49)
- Sexual functioning after breast cancer: a conceptual framework for future studies. (1997) (48)
- The LIVESTRONG Survivorship Center of Excellence Network (2009) (48)
- Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints (2013) (48)
- Post‐traumatic stress symptoms in cancer survivors: relationship to the impact of cancer scale and other associated risk factors (2015) (48)
- Quality of life outcomes from the Exercise and Nutrition Enhance Recovery and Good Health for You (ENERGY)-randomized weight loss trial among breast cancer survivors (2015) (47)
- What Outcomes Matter to Patients: A Physician-Researcher Point of View (2002) (47)
- Chemotherapy use and patient treatment preferences in advanced colorectal cancer (2013) (47)
- Comparative effectiveness of sphincter-sparing surgery versus abdominoperineal resection in rectal cancer: patient-reported outcomes in National Surgical Adjuvant Breast and Bowel Project randomized trial R-04. (2015) (47)
- Assessing Care of Vulnerable Elders‐3 Quality Indicators (2007) (47)
- Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (2012) (47)
- The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members. (2006) (46)
- Effects of mindfulness training on emotional and physiologic recovery from induced negative affect (2017) (46)
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease Outcomes. The NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 Trial (2006) (46)
- Subjective or Objective Measures of Cognitive Functioning-What's More Important? (2016) (46)
- Lasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors (2019) (46)
- DNA methylation age is elevated in breast tissue of healthy women (2017) (46)
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. (2018) (45)
- Cancer survivorship research: the challenge of recruiting adult long term cancer survivors from a cooperative clinical trials group (2009) (44)
- Quality of life and the patient with cancer. Individual and policy implications. (1994) (44)
- Development and validation of a physical examination scale to assess vaginal atrophy and inflammation. (1999) (44)
- Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems—Evaluation System (HOPES) (1993) (44)
- Variation in Physician-patient Discussion of Breast Reconstruction (2008) (43)
- Developing a Reliable, Valid, and Feasible Plan for Quality-of-Care Measurement for Cancer: How Should We Measure? (2002) (43)
- Chemotherapy-Associated Peripheral Neuropathy in Patients With Early-Stage Breast Cancer: A Systematic Review. (2018) (42)
- Abstract GS4-04: Primary results of NSABP B-39/RTOG 0413 (NRG Oncology): A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer (2019) (42)
- Psychosocial issues in lung cancer patients. (1995) (42)
- Differential impact of endocrine therapy and chemotherapy on quality of life of breast cancer survivors: a prospective patient-reported outcomes analysis. (2019) (42)
- Measuring the impact of cancer: a comparison of non-Hodgkin lymphoma and breast cancer survivors (2009) (42)
- Agreement between breast cancer risk estimation methods. (1996) (41)
- Childhood Adversity and Inflammation in Breast Cancer Survivors (2014) (40)
- Cancer Quality Alliance: Blueprint for a Better Cancer Care System (2008) (40)
- Psychometric properties of a tool for measuring hormone‐related symptoms in breast cancer survivors (2006) (40)
- Screening by the prostate-specific antigen test: what do the patients know? (2009) (39)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (39)
- Psychometric Evaluation of the Brief Cancer Impact Assessment among Breast Cancer Survivors (2006) (39)
- Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. (2009) (39)
- Menopause and breast cancer: symptoms, late effects, and their management. (2001) (39)
- Rehabilitation needs and breast cancer: The first month after primary therapy (1987) (38)
- Results of a randomized controlled trial to increase colorectal cancer screening in a managed care health plan (2005) (37)
- Associations between Single Nucleotide Polymorphisms in Double-Stranded DNA Repair Pathway Genes and Familial Breast Cancer (2009) (37)
- Biomarkers of aging associated with past treatments in breast cancer survivors (2017) (37)
- Use of imaging and biomarker tests for posttreatment care of early‐stage breast cancer survivors (2013) (37)
- The case identification challenge in measuring quality of cancer care. (2002) (37)
- Predictors of colorectal cancer screening from patients enrolled in a managed care health plan (2008) (36)
- Identifying Cancer-Related Cognitive Impairment Using the FACT-Cog Perceived Cognitive Impairment (2019) (36)
- Physicians’ Beliefs About Breast Cancer Surveillance Testing are Consistent With Test Overuse (2013) (36)
- Cigarette Smoking, Physical Activity, and Alcohol Consumption as Predictors of Cancer Incidence among Women at High Risk of Breast Cancer in the NSABP P-1 Trial (2014) (36)
- Are primary care providers prepared to care for survivors of breast cancer in the safety net? (2015) (36)
- Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. (2017) (36)
- NSABP B-30: definitive analysis of patient outcome from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer. (2009) (35)
- The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline. (2022) (35)
- NIH State-of-the-Science Conference Statement: Role of active surveillance in the management of men with localized prostate cancer. (2011) (35)
- Translation and validation of a quality of life instrument for hispanic American cancer patients: methodological considerations (1995) (35)
- Breast and ovarian cancer risk and risk reduction in Jewish BRCA1/2 mutation carriers. (2012) (34)
- Effect of timed incentives on subject participation in a study of long-term breast cancer survivors: are there ethnic differences? (2000) (34)
- Patient-Centered Communication and Shared Decision Making (2013) (34)
- Addressing the American health-care cost crisis: role of the oncology community. (2013) (34)
- Application of Assessing Care of Vulnerable Elders‐3 Quality Indicators to Patients with Advanced Dementia and Poor Prognosis (2007) (34)
- Cost-effectiveness of Universal BRCA1/2 Screening: Evidence-Based Decision Making. (2015) (33)
- The 'three Ps' of cancer survivorship care (2011) (33)
- A Comprehensive Approach to the Assessment of Cancer Patients' Rehabilitation Needs (1987) (33)
- Cognitive performance in survivors of breast cancer and markers of biological aging (2018) (33)
- Development of a text messaging system to improve receipt of survivorship care in adolescent and young adult survivors of childhood cancer (2017) (32)
- Impact of Survivorship-Based Research on Defining Clinical Care Guidelines (2011) (32)
- Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014. (2015) (32)
- Validation of Self-reported Colorectal Cancer (CRC) Screening in a Study of Ethnically Diverse First-Degree Relatives of CRC Cases (2008) (32)
- Val66Met BDNF polymorphism as a vulnerability factor for inflammation-associated depressive symptoms in women with breast cancer. (2016) (32)
- "Doctor, will the treatment you are recommending cause chemobrain?". (2012) (31)
- Journal of Clinical Oncology update on progress in cancer survivorship care and research. (2012) (31)
- Economic evaluation alongside a clinical trial of psycho-educational interventions to improve adjustment to survivorship among patients with breast cancer. (2008) (31)
- Age and gender as factors in cancer therapy. (1993) (31)
- The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment (2018) (30)
- Evaluation of a Radioimmunoassay for α1-Acid Glycoprotein To Monitor Therapy of Cancer Patients (1983) (30)
- Toward a better understanding of health-related quality of life: a comparison of the Medical Outcomes Study HIV Health Survey (MOS-HIV) and the HIV Overview of Problems-Evaluation System (HOPES). (1998) (30)
- Neuropsychological studies in breast cancer: in search of chemobrain (2009) (30)
- Quality of life and symptoms in long-term survivors of colorectal cancer: results from NSABP protocol LTS-01 (2017) (30)
- Journey forward: the new face of cancer survivorship care. (2011) (29)
- Advocating for the woman with breast cancer (1995) (29)
- Quality-of-life issues in patients with ductal carcinoma in situ. (2010) (29)
- Are older breast carcinoma survivors willing to take hormone replacement therapy? (1999) (29)
- Symptoms and QOL as Predictors of Chemoprevention Adherence in NRG Oncology/NSABP Trial P-1. (2016) (29)
- Charting a new course for the delivery of high-quality cancer care. (2013) (29)
- The use of mobile technology and peer navigation to promote adolescent and young adult (AYA) cancer survivorship care: results of a randomized controlled trial (2019) (28)
- Improving Breast Cancer Quality of Care with the Use of Patient Navigators (2010) (28)
- Evaluation of three biochemical markers for serially monitoring the therapy of small-cell lung cancer. (1987) (28)
- Long-term Cardiovascular Outcomes Among Endometrial Cancer Survivors in a Large, Population-Based Cohort Study (2018) (28)
- Clinical trials. Concerns of the patient and the public (1990) (27)
- Positive Affect and Inflammatory Activity in Breast Cancer Survivors: Examining the Role of Affective Arousal (2016) (27)
- Sexual functioning and intimacy in African American and white breast cancer survivors: a descriptive study. (1998) (27)
- Low-Income Women with Abnormal Breast Findings: Results of a Randomized Trial to Increase Rates of Diagnostic Resolution (2010) (27)
- Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector? (2005) (27)
- How much do cancer‐related symptoms contribute to health‐related quality of life in lung and colorectal cancer patients? A report from the Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium (2015) (27)
- Weight gain prior to entry into a weight-loss intervention study among overweight and obese breast cancer survivors (2014) (27)
- Use of interpreters by physicians treating limited English proficient women with breast cancer: results from the provider survey of the Los Angeles Women's Health Study. (2010) (27)
- Treatment of Nonmetastatic Breast Cancer. (2019) (26)
- Psychosocial issues in lung cancer patients (Part 2). (1991) (26)
- Assessing the quality of life of HIV infected persons: Clinical and descriptive information from studies with the hopes (1994) (26)
- Risk Factors for Cardiovascular Disease Among Thyroid Cancer Survivors: Findings From the Utah Cancer Survivors Study (2018) (26)
- Prometastatic Molecular Profiles in Breast Tumors From Socially Isolated Women (2018) (26)
- Delivering High-Quality Cancer Care: The Critical Role of Quality Measurement. (2014) (26)
- Testing a biobehavioral model of fatigue before adjuvant therapy in women with breast cancer (2019) (26)
- Expanding our therapeutic options: Beta blockers for breast cancer? (2011) (26)
- Quantitative and qualitative assessment of a case management program for cancer patients. (1991) (26)
- Depression and vasomotor symptoms in young breast cancer survivors: the mediating role of sleep disturbance (2015) (26)
- Symptoms: Fatigue and Cognitive Dysfunction. (2015) (25)
- Quality-of-life assessment in cancer clinical trials: a status report. (1992) (25)
- The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries (2019) (25)
- Compliance with patient-reported outcomes in multicenter clinical trials: methodologic and practical approaches. (2007) (24)
- Methods of Assessing the Effect of Drug Therapy on Quality of Life (1990) (24)
- Evaluating Treatment Tolerability in Cancer Clinical Trials Using the Toxicity Index (2020) (24)
- Cognitive function following breast cancer treatment and associations with concurrent symptoms (2018) (24)
- Institute of Medicine report on delivery of high-quality cancer care. (2014) (24)
- Monitoring the Therapy of Lung Cancer with α-1-Acid Glycoprotein (1984) (24)
- Does (or should) chronologic age influence the choice of cancer treatment? (1992) (24)
- Compliance with quality of life data collection in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial. (1998) (24)
- Cosmetic Outcome from Post Lumpectomy Whole Breast Irradiation (WBI) Versus Partial Breast Irradiation (PBI) on the NRG Oncology/NSABP B39-RTOG 0413 Phase III Clinical Trial (2019) (23)
- Aging-Related Disease Risks among Young Thyroid Cancer Survivors (2017) (23)
- Advanced age and adjuvant tamoxifen prescription in early‐stage breast carcinoma patients (2002) (23)
- The associations between living conditions, demography, and the ‘impact of cancer’ scale in tumor-free cancer survivors: a NOCWO study (2007) (22)
- Interaction between the physician and the older patient (1997) (22)
- Female sexual desire--beyond testosterone. (2007) (22)
- "From Snail Mode to Rocket Ship Mode": Adolescents and Young Adults' Experiences of Returning to Work and School After Hematopoietic Cell Transplantation. (2017) (22)
- Breast cancer risk variants at 6 q 25 display different phenotype associations and regulate ESR 1 , RMND 1 and CCDC 170 (2016) (22)
- BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry (2019) (22)
- A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers (2012) (22)
- Disparities in the survivorship experience among Latina survivors of breast cancer (2018) (21)
- Cancer prevention and the American Society of Clinical Oncology. (2004) (21)
- Improving the quality of cancer care in America through health information technology (2014) (21)
- Using breast cancer quality indicators in a vulnerable population (2011) (21)
- Survivorship, Version 1.2021. (2021) (21)
- Lung cancer in younger patients. (1980) (21)
- Improving Outcomes for Breast Cancer Survivors (2015) (20)
- Long‐range effect of clinical trial interventions on quality of life (1994) (20)
- Relationship between arm morbidity and patient-reported outcomes following surgery in women with node-negative breast cancer: NSABP protocol B-32. (2012) (20)
- COMMITTEE ON IMPROVING THE QUALITY OF CANCER CARE: ADDRESING THE CHALLENGES OF AN AGING POPULATION (2013) (20)
- Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 (2016) (20)
- Is hormone replacement therapy (HRT) following risk-reducing salpingo-oophorectomy (RRSO) in BRCA1 (B1)- and BRCA2 (B2)-mutation carriers associated with an increased risk of breast cancer? (2011) (20)
- Symptoms: Menopause, Infertility, and Sexual Health. (2015) (20)
- Follow-up of long-term cancer survivors in the Nordic countries (2007) (20)
- Organizational systems used by California capitated medical groups and independent practice associations to increase cancer screening (2000) (20)
- Improving colorectal cancer screening rates in a managed care health plan: recruitment of provider organizations for a randomized effectiveness trial. (2003) (19)
- Do all patients with cancer experience fatigue? A longitudinal study of fatigue trajectories in women with breast cancer (2021) (19)
- Multiple synchronous lesions of acral metastasis. (1984) (19)
- Is there a relationship between posttraumatic stress and growth after a lymphoma diagnosis? (2014) (19)
- Acceptability of Mobile Mammography Among Community‐Dwelling Older Women (1997) (19)
- The Relationship Among Physicians’ Specialty, Perceptions of the Risks and Benefits of Adjuvant Tamoxifen Therapy, and Its Recommendation in Older Patients With Breast Cancer (2004) (19)
- Primary results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) versus tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy. (2015) (19)
- Genetic Variation in IGF2 and HTRA1 and Breast Cancer Risk among BRCA1 and BRCA2 Carriers (2011) (18)
- Childhood maltreatment and monocyte gene expression among women with breast cancer (2020) (18)
- Cortisol Awakening Response as a Prospective Risk Factor for Depressive Symptoms in Women After Treatment for Breast Cancer (2017) (18)
- Yoga for Persistent Fatigue in Breast Cancer (2011) (18)
- The price of anticancer intervention (2002) (18)
- Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors (2015) (18)
- Assessing the impact of cancer among Dutch non‐Hodgkin lymphoma survivors compared with their American counterparts: a cross‐national study (2013) (18)
- Presenting comparative study PRO results to clinicians and researchers: beyond the eye of the beholder (2017) (18)
- Feasibility of a randomized controlled trial of vitamin D vs. placebo in women with recently diagnosed breast cancer (2012) (18)
- Long-term, adverse genitourinary outcomes among endometrial cancer survivors in a large, population-based cohort study. (2017) (18)
- Patient Education as a Moderator of Psychological Distress (1989) (17)
- Pro‐inflammatory cytokines and depression in a familial cancer registry (2007) (17)
- Clinical trials. Concerns of the patient and the public. (1990) (17)
- Bone mineral density and adjuvant therapy in breast cancer survivors (2004) (17)
- Randomized trial to increase colorectal cancer screening in an ethnically diverse sample of first‐degree relatives (2015) (17)
- Addressing the Survivorship Care Needs of Patients Receiving Extended Cancer Treatment. (2017) (17)
- Childhood maltreatment, psychological resources, and depressive symptoms in women with breast cancer. (2017) (17)
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (2018) (17)
- Outcomes Assessment in Cancer: Quality of life in breast cancer: what have we learned and where do we go from here? (2004) (17)
- Comprehensive Menopausal Assessment: An Approach to Managing Vasomotor and Urogenital Symptoms in Breast Cancer Survivors (2003) (17)
- Assessing the quality and value of quality-of-life measurement in breast cancer clinical trials. (2011) (16)
- Provider perceptions and expectations of breast cancer posttreatment care: a University of California Athena Breast Health Network project (2013) (16)
- Routine preventive care and cancer surveillance in long-term survivors of colorectal cancer: results from National Surgical Adjuvant Breast and Bowel Project Protocol LTS-01. (2010) (16)
- Menopause and breast cancer: addressing the secondary health effects of adjuvant chemotherapy. (2001) (16)
- Medicare Payment Policy Creates Incentives For Long-Term Care Hospitals To Time Discharges For Maximum Reimbursement. (2015) (16)
- Amenorrhea in premenopausal women on the doxorubicin (A) and cyclophosphamide (C) → docetaxel (T) arm of NSABP B-30: Preliminary results (2005) (16)
- A procedure for obtaining Impact of Cancer version 2 scores using version 1 responses (2013) (16)
- Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
- Economic Evaluation in the Journal of Clinical Oncology: Past, Present, and Future (2007) (16)
- Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers (2012) (16)
- Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers (2011) (16)
- Physician and practice characteristics influencing tumor board attendance: Results from the provider survey of the Los Angeles Women's Health Study. (2009) (16)
- Cancer-related accelerated ageing and biobehavioural modifiers: a framework for research and clinical care (2021) (16)
- "Winging It": How Older Breast Cancer Survivors Persist With Aromatase Inhibitor Treatment. (2016) (16)
- Financial and work related impact of cancer in young adult (YA) survivors. (2016) (15)
- Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
- Quality Health Care for Cancer Survivors (2011) (15)
- Management of cancer in the older patient (2012) (15)
- Estrogen, tamoxifen, and the brain. (2002) (15)
- Does a history of childhood sexual abuse affect sexual outcomes in breast cancer survivors? (2005) (14)
- Quality-of-Life and Psychosocial Oncology Research in Europe (1991) (14)
- Prevalence, predictors, and patient outcomes associated with physician co-management: findings from the Los Angeles Women's Health Study. (2012) (14)
- Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer (2008) (14)
- Rehabilitation of patients with primary breast cancer: assessing the impact of adjuvant therapy. (1989) (14)
- Quality of life measures in cancer chemotherapy: methodology and implications. (1994) (14)
- Measuring cognitive complaints in breast cancer survivors: psychometric properties of the patient’s assessment of own functioning inventory (2016) (14)
- The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project. (2008) (14)
- Financial incentives for quality in breast cancer care. (2008) (13)
- Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial (2016) (13)
- Characteristics of Breast Cancer Survivors That Predict Partners' Participation in Research (2013) (13)
- Implementing palliative care studies. (2007) (13)
- The status of cancer rehabilitation in the late 1990s. (1999) (13)
- Potential Mechanisms of Age Acceleration Caused by Estrogen Deprivation: Do Endocrine Therapies Carry the Same Risks? (2018) (13)
- Health-related quality-of-life findings for the prostate cancer prevention trial. (2012) (13)
- Cancer treatment and cognitive function: chemotherapy is not the only culprit. (2014) (13)
- Cancer Control and (the Older Person (1991) (12)
- Managing Menopausal Symptoms in Breast Cancer Survivors. (1995) (12)
- Development and pilot testing of a psychosocial intervention program for young breast cancer survivors. (2016) (12)
- Breast Cancer Research and Treatment 2001 Reviewers (2004) (12)
- Cancer patients' attitudes toward hospice services (1984) (12)
- Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study (2014) (12)
- Counseling Cancer Patients About Changes in Sexual Function (1999) (12)
- Cancer‐related impairments and functional limitations among long‐term cancer survivors: Gaps and opportunities for clinical practice (2021) (12)
- Health-related quality of life measurement in symptom management trials. (2007) (12)
- Cognitive Impairment in Patients With Breast Cancer: Understanding the Impact of Chemotherapy and Endocrine Therapy. (2020) (11)
- National Outcomes in Hospitalized Patients With Cancer and Comorbid Heart Failure. (2019) (11)
- Harnessing personalised medicine to prevent late effects. (2010) (11)
- Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors (2016) (11)
- Coming of Age With Cancer: Physical, Social, and Financial Barriers to Independence Among Emerging Adult Survivors (2018) (11)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
- Reproductive and gynecological complication risks among thyroid cancer survivors (2018) (11)
- Abstract OT2-2-04: A phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/− one year of everolimus in patients with high-risk, hormone receptor- (HR) positive and HER2-negative breast cancer: SWOG/NSABP S1207. (2012) (11)
- Improving breast cancer survivors' knowledge using a patient-centered intervention. (2015) (10)
- Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography (2017) (10)
- Gaps in survivorship care plan delivery and potential benefits to survivorship care. (2013) (10)
- Inflammation and attentional bias in breast cancer survivors (2017) (10)
- Current US Cancer Statistics: Alarming trends in young adults? (2019) (10)
- Host factors, behaviors, and clinical trials: opportunities and challenges. (2012) (10)
- Prostate cancer: the price of early detection. (2001) (10)
- Special Issues in Younger Women with Breast Cancer. (2015) (10)
- Survival in Acute Leukemia in Elderly Patients (1991) (10)
- Improving Outcomes for Breast Cancer Survivors : Perspectives on Research Challenges and Opportunities (2015) (10)
- Pediatric cancer survivorship: the Childhood Cancer Survivor Study--editor's foreword. (2009) (10)
- Monitoring the therapy of lung cancer with alpha-1-acid glycoprotein. (1984) (10)
- ESMO Expert Consensus Statements on Cancer Survivorship: promoting high-quality survivorship care and research in Europe. (2022) (10)
- The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers (2012) (10)
- Comparison of Two Multiple Imputation Procedures in a Cancer Screening Survey (2003) (10)
- The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant (2021) (10)
- Abstract OT1-03-11: Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor (HR) positive and HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140) (2015) (10)
- Cancer-Related Cognitive Impairment in Patients With a History of Breast Cancer. (2021) (9)
- Methodological Issues in the Analysis of Quality of Life Data in Clinical Trials: Illustrations from the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial (2002) (9)
- Development and Validation of a Predictive Model of Severe Fatigue After Breast Cancer Diagnosis: Toward a Personalized Framework in Survivorship Care (2022) (9)
- The Structural Landscape of the Health Care System for Breast Cancer Care: Results from The Los Angeles Women’s Health Study (2009) (9)
- Health services for cancer survivors : practice, policy and research (2011) (9)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2016) (9)
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
- Tracking managed care: the importance of a cash incentive for medical director response to a survey. (2000) (9)
- Adjuvant chemotherapy use and outcomes in older women with breast cancer: what have we learned? (2006) (9)
- A phase III randomized trial of metformin versus placebo on recurrence and survival in early-stage breast cancer (BC) (NCIC Clinical Trials Group MA.32). (2011) (9)
- Doctor, Now That My Chemotherapy Treatment Is Over, When Will My "Chemofog" Lift? (2017) (9)
- Comparison of Neurocognitive Function After Anthracycline-Based Chemotherapy vs Nonanthracycline-Based Chemotherapy. (2016) (9)
- Cancer Survivorship Plans: A Paradigm Shift in the Delivery of Quality Cancer Care (2011) (9)
- Changes in Body Mass Index and Physical Activity Predict Changes in Vitality During a Weight Loss Trial in Breast Cancer Survivors. (2018) (9)
- Does circulating tumor necrosis factor (TNF) play a role in post-chemotherapy cerebral dysfunction in breast cancer survivors (BCS)?. (2011) (8)
- Endocrine and Metabolic Diseases among Colorectal Cancer Survivors in a Population-Based Cohort. (2017) (8)
- Quality of Care, Including Survivorship Care Plans. (2015) (8)
- Breast Cancer 2002: Where Do We Stand? (2002) (8)
- Angina pectoris after doxorubicin and mitomycin therapy. (1983) (8)
- Evaluation of a radioimmunoassay for alpha 1-acid glycoprotein to monitor therapy of cancer patients. (1983) (8)
- Psychosocial and Physical Health in Post‐treatment and Extended Cancer Survivorship (2012) (8)
- Long-Term Longitudinal Patterns of Patient-Reported Fatigue After Breast Cancer: A Group-Based Trajectory Analysis (2022) (8)
- Behavioral science research in the cooperative group setting: the Southwest Oncology Group experience. (2000) (8)
- The role of families in decisions about cancer treatments. (2013) (8)
- The study of tamoxifen and raloxifene (STAR): First report of patient-reported outcomes (PROs) from the NSABP P-2 Breast Cancer Prevention Study. (2006) (7)
- Managed care market share and primary treatment for cancer. (2006) (7)
- Patient-reported outcomes (PROs) in NRG oncology/NSABP B-39/RTOG 0413: A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) in stage 0, I, or II breast cancer. (2019) (7)
- The role of hormones in breast carcinogenesis: issues of relevance to female childhood cancer survivors. (2001) (7)
- Targeting Depressive Symptoms in Younger Breast Cancer Survivors: The Pathways to Wellness Randomized Controlled Trial of Mindfulness Meditation and Survivorship Education (2021) (7)
- Modification of BRCA 1-Associated Breast and Ovarian Cancer Risk by BRCA 1-Interacting Genes (2011) (7)
- Erratum to: 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1 (2012) (7)
- Incorporating the Risk for Subsequent Primary Cancers Into the Care of Adult Cancer Survivors: Moving Beyond 5-Year Survival. (2020) (7)
- Cancer survivorship care for young adults: a risk-stratified, multicenter randomized controlled trial to improve symptoms (2021) (7)
- Early dissemination of bevacizumab for advanced colorectal cancer: a prospective cohort study (2011) (7)
- Comparison of the impact of cancer between British and US long-term non-Hodgkin lymphoma survivors (2017) (7)
- Moderators of inflammation-related depression: a prospective study of breast cancer survivors (2021) (7)
- NSABP B-47: A randomized phase III trial of adjuvant therapy comparing chemotherapy alone to chemotherapy plus trastuzumab in women with node-positive or high-risk node-negative HER2-low invasive breast cancer. (2013) (6)
- Vulnerability to inflammation-related depressive symptoms: Moderation by stress in women with breast cancer (2021) (6)
- Cigarette smoking, fitness, and alcohol use as predictors of cancer outcomes among women in the National Surgical Adjuvant Breast and Bowel Project (NSABP) Breast Cancer Prevention Trial (BCPT). (2011) (6)
- Painful Hands and Feet After Cancer Treatment: Inflammation Affecting the Mind-Body Connection. (2016) (6)
- Living with Metastatic Breast Cancer. (2015) (6)
- Recruitment and Retention Challenges in Breast Cancer Survivorship Research (2003) (6)
- Engaging Latino Adolescent and Young Adult (AYA) Cancer Survivors in Their Care: Piloting a Photonovela Intervention (2020) (6)
- Quality of Life Assessment in Breast Cancer: When Does it Add Prognostic Value for Survival? (2011) (6)
- Final updated results of the NRG Oncology/NSABP Protocol P-2: Study of Tamoxifen and Raloxifene (STAR) in preventing breast cancer. (2015) (6)
- Delivering on the promise of patient-centered care. (2015) (6)
- The Survivorship Care Plan: What, Why, How, and for Whom (2007) (6)
- Do we need a new end point in clinical trials today? (1989) (6)
- Genetic Variation in IGF 2 and HTRA 1 and Breast Cancer Risk among BRCA 1 and BRCA 2 Carriers (2011) (6)
- Practice-Changing Strategies to Deliver Affordable, High-Quality Cancer Care: Summary of an Institute of Medicine Workshop. (2013) (6)
- Understanding the Workplace Interactions of Young Adult Cancer Survivors With Occupational and Environmental Health Professionals (2019) (6)
- Challenges and Opportunities in Delivering High-Quality Cancer Care: A 2016 Update. (2016) (6)
- Socioeconomic Status and Inflammation in Women with Early-stage Breast Cancer: Mediation by Body Mass Index (2021) (6)
- Patient Adherence to Cancer Control Regimens (1993) (6)
- Cancer survivors: a look backward and forward. (2014) (6)
- The Effects of Lifetime Estrogen Exposure on Breast Epigenetic Age (2021) (5)
- Cancer Prevention and Control: Then and Now (2018) (5)
- NSABP B-30: definitive analysis of quality of life (QOL) and menstrual history (MH) outcomes from a randomized trial evaluating different schedules and combinations of adjuvant therapy containing doxorubicin, docetaxel and cyclophosphamide in women with operable, node-positive breast cancer. (2009) (5)
- Anti-mullerian hormone as a serum biomarker for risk of chemotherapy-induced amenorrhea. (2020) (5)
- Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study: A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instability high (MSI-H) metas (2021) (5)
- Improving the Quality and Value of Cancer Care: A Work in Progress-The 2016 Joseph V. Simone Award and Lecture. (2016) (5)
- Cognitive dysfunction associated with chemotherapy for breast cancer (2007) (5)
- Electronic monitoring of participant adherence in the NSABP breast cancer prevention trial (BSPT) (1998) (5)
- Post-traumatic Stress Symptoms in Cancer Survivors (2015) (5)
- Screening for Depression in Younger Breast Cancer Survivors: Outcomes From Use of the 9-item Patient Health Questionnaire (2021) (5)
- Understanding Cancer Patients' Experience and Outcomes (2006) (5)
- Process of diffusing cancer survivorship care into oncology practice (2013) (5)
- Disparities in breast cancer care and research: report from a Breast Cancer Research Foundation sponsored workshop, 9–10 October 2014 (2015) (5)
- Quality of life research: clinical applications. (1998) (5)
- Surveillance and monitoring in breast cancer survivors: maximizing benefit and minimizing harm. (2013) (5)
- NRG-GI004/SWOG-S1610: Colorectal Cancer Metastatic dMMR Immuno-Therapy (COMMIT) Study—A randomized phase III study of atezolizumab (atezo) monotherapy versus mFOLFOX6/bevacizumab/atezo in the first-line treatment of patients (pts) with deficient DNA mismatch repair (dMMR) or microsatellite instabili (2021) (5)
- Developing a Comprehensive Network of Rehabilitation Resources for Referral of Cancer Patients (1987) (5)
- Identifying tools and strategies to provide quality oncology care. (2013) (5)
- Delivering Patient-Centered Care in the Setting of Advanced Cancer: What Does a Clinical Risk-Prediction Model Have to Do With It? (2015) (5)
- Nutrition and breast cancer. (1993) (5)
- Follow-up care for breast cancer survivors. (2019) (4)
- Goal disturbance in early-stage breast cancer survivors (2019) (4)
- Symptomatic response to a non-platinum doublet in performance status 2 (PS 2) patients (pts) with non-small lung cancer (NSCLC). (2004) (4)
- Improving the Evidence Base for Delivery of High-Quality Cancer Care. (2017) (4)
- Neurotoxicity (NT) in colon cancer (CC) survivors from NSABP Protocol C-07 comparing 5-FU + leucovorin (FULV) with the same regimen + oxaliplatin (FLOX): Preliminary results from NSABP Protocol LTS-01 (2008) (4)
- Reply to U. Tirelli et al. (2014) (4)
- Are Patients Making High-Quality Decisions about Breast Reconstruction after Mastectomy?: Lee CN, Belkora J, Chang Y, et al (Univ of North Carolina, Chapel Hill; Univ of California, San Francisco; Harvard Med School, Boston, MA) Plast Reconstr Surg 127:18-26, 2011§ (2011) (4)
- Predictors of vitality (energy/fatigue) in early stage Hodgkin's disease (HD): Results from Southwest Oncology Group (SWOG) Study 9133. (2004) (4)
- A comparison of quality of life in colon cancer patients receiving adjuvant uracil/ftorafur + leucovorin versus 5-fluorouracil + leucovorin in NSABP C-06 (2005) (4)
- Communicating Risks of Adjuvant Chemotherapy for Breast Cancer: Getting Beyond the Laundry List. (2019) (4)
- Cancer Rehabilitation Evaluation System (CARES) and CARES-SF now publicly available. (2012) (4)
- Cancer Survivors: A Physician’s Perspective (2007) (4)
- Trajectories of C-reactive protein in the year after breast cancer treatment (2017) (4)
- Patient-reported outcomes (PROs) comparison of 5-FU and capecitabine (cape) with concurrent radiotherapy (RT) for neoadjuvant treatment of rectal cancer: Results of NSABP R-04. (2012) (4)
- Improving the Quality of Health Care for Older Adults (2008) (4)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
- Addressing the Survivorship Care Needs of Patients Receiving Extended Cancer Treatment. (2017) (4)
- Neurocognitive performance in breast cancer survivors (BCS): Exploring the relationship with adjuvant treatment, psychological and reproductive factors (2004) (4)
- Men's adjustment after their partners' complete treatment for localized breast cancer. (2012) (4)
- Symptoms After Breast Cancer Treatment (2008) (4)
- Motivations associated with physical activity in young breast cancer survivors (2015) (3)
- Continuing education: Comprehensive menopausal assessment: an approach to managing vasomotor and urogenital symptoms in breast cancer survivors. (2003) (3)
- A phase II clinical trial platform utilizing total neoadjuvant therapy (TNT) in rectal cancer: Nrg-GI002. (2016) (3)
- Understanding patient preferences for involvement in care. (1997) (3)
- Assessing the Quality of Rectal Cancer Pathology Reports in National Surgical Adjuvant Breast and Bowel Project Protocol R-04/NRG Oncology (2020) (3)
- Symptom Management After Breast Cancer Treatment (2008) (3)
- COMPARING IMPUTATION OF ENTIRE SUBSCALES VERSUS INDIVIDUAL ITEMS IN A STUDY OF QUALITY OF LIFE FOLLOWING BREAST CANCER (2002) (3)
- Acute and Chronic Effects of Adjuvant Therapy on Inflammatory Markers in Breast Cancer Patients (2022) (3)
- Adjuvant Therapy for Breast Cancer: No Pain, No Gain? (2006) (3)
- Evaluating treatment tolerability using the toxicity index with patient-reported outcomes data. (2021) (3)
- Prediction of Breast Cancer Treatment–Induced Fatigue by Machine Learning Using Genome-Wide Association Data (2020) (3)
- Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004 (2021) (3)
- Patient-reported neurotoxicity with FULV versus FLOX in patients with stage II or III carcinoma of the colon: Results of NSABP Protocol C-07. (2016) (3)
- S39 Impact of different adjuvant therapy strategies on quality of life (QOL) in breast cancer survivors (BCS) (1998) (3)
- Quality of Life Measures in Cancer Chemotherapy (1994) (3)
- Controversy about mammography screening guidelines and physician practices at a university medical center. (2009) (3)
- Understanding the impact of breast cancer adjuvant endocrine therapy on cognitive function: a work in progress (2016) (3)
- Fat igue in Breast Cancer Surv ivors : Occurrence , Corre lates , and Impact on Qual i ty of Li fe (2000) (3)
- An analysis of vitamin D (Vit D) and serum estrogens in postmenopausal (PM) breast cancer (BC) patients receiving aromatase inhibitors (AIs). (2011) (3)
- Physician and Practice Characteristics Influencing Tumor Board Attendance: Results From the Provider Survey of the Los Angeles Women's Health Study. (2011) (3)
- Implementing the Survivorship Care Plan: A Strategy for Improving the Quality of Care for Cancer Survivors (2010) (3)
- Institute of medicine report: recognizing psychosocial health needs to treat the whole patient. (2008) (3)
- Professional attitudes toward hospice care. (1985) (3)
- Health Services Utilisation in Breast Cancer Survivors in Taiwan (2014) (3)
- Dynamics of Long-Term Patient-Reported Quality of Life and Health Behaviors After Adjuvant Breast Cancer Chemotherapy (2022) (2)
- Quality of life in breast cancer patients receiving sentinel-node (SN) biopsy alone or with axillary dissection (AD): Results from NSABP Protocol B-32 (2008) (2)
- Quality of Posttreatment Care Among Breast Cancer Survivors in the University of California Athena Breast Health Network (Athena). (2016) (2)
- Physical late effects of cancer: Implications for care. (2009) (2)
- Notable Advances in clinical oncology 2010. (2010) (2)
- NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab (2021) (2)
- The Workforce Caring for Patients with Cancer (2013) (2)
- Tracking Managed Care (2000) (2)
- Journey forward: the new face of cancer survivorship care. (2011) (2)
- Challenges and Opportunities in Delivering High-Quality Cancer Care: A 2016 Update. (2016) (2)
- Measuring Outcomes and Health-Related Quality of Life (2001) (2)
- Seven-year follow-up for energy/vitality outcomes in early stage Hodgkin’s disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208 (2017) (2)
- A comparison of primary care providers’ and oncologists’ preferences for different models of cancer survivorship care. (2012) (2)
- Estimating the Human Costs of Cancer Survivorship in Children (2010) (2)
- Impact of cancer on physical and mental activities of daily living in young adult (YA) survivors. (2019) (2)
- Psychosocial Resilience to Inflammation-Associated Depression: A Prospective Study of Breast-Cancer Survivors (2022) (2)
- Fatigue in long-term non-Hodgkin lymphoma survivors. (2015) (2)
- Double blind phase III trial of placebo (P) vs. megestrol acetate (MA) 20 mg vs. MA 40 mg as treatment for symptoms of ovarian failure in breast cancer survivors: Initial results of Southwest Oncology Group S9626 (2001) (2)
- Abstract P5-13-09: Feasibility of a Randomized Controlled Trial of Vitamin D vs. Placebo in Recently Diagnosed Breast Cancer Patients (2010) (2)
- Attitudes of cancer patients. (1980) (2)
- Barriers in providing breast and colorectal cancer survivorship care: Perceptions of U.S. primary care physicians (PCPs) and medical oncologists (MOs). (2011) (2)
- Can we find the positive in negative clinical trials? (2019) (2)
- Appendix to Application of ACOVE-3 Quality Indicators to Patients with Advanced Dementia and Poor Prognosis (Appendices 1 & 2 and Figures 1 & 2) (2007) (2)
- P117 Exemestane (EXE) as extended adjuvant therapy after 5 years of tamoxifen (TAM): results of NSABP B-33 (2007) (2)
- Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy with or without one year of everolimus in patients with high-risk, hormone receptor- (HR) positive and HER2-neu-negative breast cancer: SWOG/NSABP S1207. (2013) (2)
- Toxicity Index, Patient-Reported Outcomes, and Early Discontinuation of Endocrine Therapy for Breast Cancer Risk Reduction in NRG Oncology/NSABP B-35 (2021) (2)
- Breakout III. Concerns of the patient and the public (1990) (2)
- Abstract P3-12-01: Impact of treatment on quality of life (QOL) and menstrual history (MH) in the NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (2015) (2)
- Visualizing adverse events in clinical trials using correspondence analysis with R-package visae (2021) (2)
- Cancer Survivorship Issues in Colorectal Cancer (2007) (2)
- The inflammation complication: New evidence in cancer-related cognitive impairment (2019) (2)
- Comparative effectiveness of sphincter-sparing surgery (SSS) versus abdomino-perineal resection (APR) in rectal cancer: Patient-reported outcomes (PROs) from NSABP R-04. (2012) (2)
- Breast cancer (BC) related fatigue: A longitudinal investigation of its prevalence, domains and correlates. (2018) (2)
- REVIEW Arm Edema in Breast Cancer Patients (2001) (2)
- Quality of Life and Cancer Rehabilitation (1999) (2)
- Executive Functioning and Depressive Symptoms After Cancer: The Mediating Role of Coping (2021) (2)
- Association of APOE4 genotype and treatment with cognitive outcomes in breast cancer survivors over time (2021) (2)
- Neurocognitive performance in breast cancer following exposure to adjuvant systemic therapy (2001) (2)
- A qualitative study to evaluate physician attitudes regarding omission of surgery among exceptional responders to neoadjuvant systemic therapy for breast cancer (NRG-CC006) (2021) (2)
- The Impact of Radiation Therapy on Lymphedema Risk and the Agreement Between Subjective and Objective Lymphedema Measures: NSABP B-32 Secondary Data Analysis (2014) (2)
- The price of anticancer intervention. Treatment-induced malignancy. (2002) (2)
- Cancer Patients' Roles in Treatment Decisions (2010) (2)
- Abstract S6-04: Patient-reported outcome (PRO) results, NRG Oncology/NSABP B-35: A clinical trial of anastrozole (A) vs tamoxifen (tam) in postmenopausal patients with DCIS undergoing lumpectomy plus radiotherapy (2016) (2)
- Breast cancer risk: is postmenopausal hormone therapy ever safe? (2005) (2)
- The Hazards of Assessing the Carcinogenicity of Agents. (2019) (2)
- Evidence map of ductal carcinoma in situ management options. (2019) (2)
- Use of advanced imaging and biomarker tests for post-treatment surveillance in early-stage breast cancer survivors. (2012) (2)
- Abstract GS2-10: Targeting depressive symptoms in younger breast cancer survivors: A randomized controlled trial of mindfulness meditation and survivorship education (2021) (2)
- “Improving to where?”: treatment-related health risks and perceptions of the future among adolescents and young adults after hematopoietic cell transplantation (2018) (1)
- Parietal and temporal cortical activity associated with cognitive symptoms and depression in chemotherapy treated breast cancer survivors 5 to 10 years after end of chemotherapy (2007) (1)
- Preliminary results from a comparative effectiveness study of breast cancer survivorship care: A University of California (UC) ATHENA Breast Health Network project. (2011) (1)
- Fertility preservation use and outcomes among young adult cancer survivors. (2018) (1)
- Accuracy of Cancer Registry Data When Treatment Is in the Ambulatory Setting (2005) (1)
- A Learning Health Care Information Technology System for Cancer (2013) (1)
- Reply to I.E. Haines. (2014) (1)
- Chapter 2 Special Issues in Younger Women with Breast Cancer (2015) (1)
- Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers (2011) (1)
- Moving the Translational Needle in Breast Cancer Survivorship: Connecting Intervention Research to Clinical Practice. (2022) (1)
- Health burden in cancer survivors: below the tip of the iceberg (2019) (1)
- Reply to P. Tralongo et al. (2017) (1)
- Comprar Health Services for Cancer Survivors · Practice, Policy and Research | Feuerstein, Michael | 9781441913470 | Springer (2011) (1)
- Biomarkers of aging associated with past treatments in breast cancer survivors (2017) (1)
- Current practice patterns and gaps in guideline-concordant breast cancer survivorship care (2021) (1)
- University of California-Los Angeles Prostate Cancer Index (2019) (1)
- Cigarette smoking, fitness, and obesity as predictors of chemoprevention adherence among women in the National Surgical Adjuvant Breast and Bowel Program (NSABP) Breast Cancer Prevention Trial (BCPT). (2010) (1)
- Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
- Health‐related quality of life outcomes after neoadjuvant chemoradiotherapy for rectal cancer in NRG Oncology/NSABP R‐04 (2022) (1)
- Behavioral and health outcomes from the NRG Oncology/NSABP B-36 trial comparing two different adjuvant therapy regimens for early-stage node-negative breast cancer (2022) (1)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in $\small \textit{BRCA1}$ and $\small \textit{BRCA2}$ Mutation Carriers (2016) (1)
- Adherence Determinants Questionnaire (ADQ) 1993 (2007) (1)
- Physician Performance Measurement Set (2008) (1)
- Comprar Cancer Survivorship · Today and Tomorrow | Ganz, Patricia A. | 9780387343495 | Springer (2007) (1)
- Relationship between the cumulative burden (CB) of chronic health conditions (CHC) and health-related quality of life (HRQoL) among childhood cancer survivors (CCS): The St. Jude Lifetime (SJLIFE) cohort. (2017) (1)
- Cancer care planning and quality improvement: 2 for the price of 1? (2013) (1)
- Late effects among young thyroid cancer survivors. (2017) (1)
- QOL Research Helps Physicians Tailor Cancer Treatment (1997) (1)
- The Study of Tamoxifen and Raloxifene (STAR): Change in patient-reported outcomes (PROs) after the end of treatment (2007) (1)
- Implementing the Survivorship Care Plan (2015) (1)
- Uterine cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations (BRCA+): A multicenter, prospective study. (2015) (1)
- Sexual Health and Functioning After Cancer (1999) (1)
- Breast Cancer Risk-Reducing Medications. (2020) (1)
- DNA Methylation, Aging, and Cancer Risk: A Mini-Review (2022) (1)
- Amphotericin B plus combination chemotherapy for extensive non-small cell bronchogenic carcinoma (2004) (1)
- NRG Oncology/NSABP B-47 menstrual history study: impact of adjuvant chemotherapy with and without trastuzumab (2021) (1)
- Accessible and Affordable Cancer Care (2013) (1)
- Predictors of use of sentinel lymph node biopsy (SNB) in a population-based cohort of breast cancer (BC) patients (pts) (2004) (1)
- Impact of cancer on employment and finances in young adult (YA) survivors. (2018) (1)
- Effects of adjuvant therapy on cerebral function during short-term and long-term memory tasks (2012) (1)
- Association of APOE4 genotype and treatment with cognitive outcomes in breast cancer survivors over time (2021) (1)
- Reply to W. Hryniuk et al. (2016) (1)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (1)
- Predictors of vitality (energy/fatigue) in early stage Hodgkin's disease (HD): Results from Southwest Oncology Group (SWOG) Study 9133 (2004) (1)
- Applying the Toxicity Index to Patient-Reported Symptom Data: An Example Using the European Organization for Research and Treatment of Cancer Colorectal Cancer-Specific Quality of Life Questionnaire. (2021) (1)
- Cognitive function following breast cancer treatment and associations with concurrent symptoms (2018) (1)
- Predictors of use of sentinel lymph node biopsy (SNB) in a population-based cohort of breast cancer (BC) patients (pts). (2004) (1)
- The Current Cancer Care Landscape: An Imperative for Change (2013) (1)
- Prospective multicenter trial to determine the feasibility of collection and predictive ability of breast fluid analysis in postmenopausal women receiving SERMs. (2007) (1)
- Improving Cancer Survivorship Care for Latino Adolescent, Young Adult Survivors Through Community-Partnered Participatory Research (2021) (1)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
- 25-hydroxy vitamin D (VitD) and associated variables as predictors of breast cancer (BC) risk and tamoxifen benefit in NSABP-P1. (2011) (0)
- Routine preventive care and cancer surveillance in long-term survivors (LTS) of colorectal cancer: Results from NSABP Protocol LTS-01. (2009) (0)
- Decline in physical functioning in first 2 years after breast cancer diagnosis to predict survival in older women. (2012) (0)
- Inclusion of a core patient-reported outcomes battery in adolescent and young adult cancer clinical trials. (2022) (0)
- Optimizing Health: Oncology Care (2011) (0)
- Relevant Endpoints for Advanced Breast Cancer Patients (2011) (0)
- Abstract 5492: Use of beta blockers, ACE inhibitors, and angiotensin receptor blockers and risk of breast cancer recurrence: A Danish nationwide cohort study (2012) (0)
- Chapter 16 Living with Metastatic Breast Cancer (2015) (0)
- Comprar Management of Cancer in the Older Patient Expert Consult - Online and Print | Patricia Ganz | 9781437713985 | Saunders (2011) (0)
- Chapter 24 – Long Term Effects and Cancer Survivorship in the Older Patient (2012) (0)
- Improving biobehavioral health in younger breast cancer survivors: Pathways to Wellness trial secondary outcomes. (2022) (0)
- Abstract PD6-11: Altered regional cerebral blood flow in adjuvant-treated breast cancer survivors after chemo- and endocrine therapy (2021) (0)
- OP-JNCI180206 1300..1310 (2018) (0)
- Age-Related Breast Cancer Therapy-Reply (1987) (0)
- Acute health-related quality of life outcomes and systemic inflammatory markers following contemporary breast cancer surgery (2022) (0)
- Abstract P4-11-01: Development of a clinico-bio-behavioral model for cancer-related fatigue (CRF) incorporating inflammatory biomarkers and proteomic data (2022) (0)
- Breast Cancer Prevention Trial Symptom Checklist--Short Form (2014) (0)
- Editorial: Changing of the Guard at the Journal of the National Cancer Institute. (2017) (0)
- Comparison of Simple-Summated Scoring and Toxicity Index Scoring of Symptom Bother in the NSABP B-30 Clinical Trial (2022) (0)
- Discharges For Maximum Reimbursement Medicare Payment Policy Creates Incentives For Long-Term Care Hospitals To Time (2015) (0)
- A radioimmunoassay for ovarian cancer. (1984) (0)
- Quality of life in men with prostate cancer A pilot study (1993) (0)
- Abstract 08: Clinical exome sequencing in the diagnosis of pediatric cancer predisposition (2014) (0)
- Abstract 4444: DNA methylation age is accelerated in breast tissue of healthy women donors (2016) (0)
- The impact of reproductive factors on DNA methylation-based telomere length in healthy breast tissue (2022) (0)
- Fatigue After Breast Cancer Treatment (2018) (0)
- What is the optimal way to evaluate quality of life in breast cancer trials? (2015) (0)
- Socioeconomic Factors and Adherence to Health Care Recommendations in Adolescent and Young Adult Cancer Survivors. (2023) (0)
- Preface to Special Edition on Breast Cancer (2005) (0)
- Addressing Diversity, Equity, and Inclusion at the JNCI Journals. (2022) (0)
- Abstract A107: Variation in the prolactin and prolactin receptor genes and familial breast cancer (2012) (0)
- Abstract P2-11-06: Differential gene expression patterns in healthy breast tissue exhibiting epigenetic age acceleration (2022) (0)
- A mixed method study of medical oncologists’ perceived barriers and motivators to addressing long-term effects in breast cancer survivors (2022) (0)
- Estradiol and breast cancer risk. (2006) (0)
- Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy Tolerability. (2021) (0)
- The value of cultivating multiple resilience factors: Effects of resilience factors on inflammation-related depression in the context of stress (2021) (0)
- Coordinating cancer care: Measurement and intervention approaches across the cancer continuum. (2013) (0)
- E16. Managing the side effects of breast cancer (2010) (0)
- Acute health-related quality of life outcomes and systemic inflammatory markers following contemporary breast cancer surgery (2022) (0)
- Abstract P1-11-01: Patients' perspectives on using a genomic test for their breast cancer treatment decisions: Disparities in information exchange (2015) (0)
- A Survivorship Educational Tool for Latino Adolescent and Young Adult Cancer Survivors (2022) (0)
- CANCER SURVIVORSHIP ISSUES IN PATIENTS WITH GASTROINTESTINAL CANCERS (2013) (0)
- q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers (2012) (0)
- Title Post-traumatic stress symptoms in cancer survivors : Relationship to the impact of cancer scale and other associated risk factors Permalink (2015) (0)
- The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer (2013) (0)
- Abstract P3-18-04: Evaluating de-escalation of breast radiation (DEBRA) following lumpectomy for breast conservative treatment of stage 1, hr+, HER2-, RS ≤18 breast cancer: NRG-BR007 a phase III trial (2022) (0)
- Chemotherapy induced amenorrhea as an indicator of better survival in early breast cancer (2010) (0)
- Exploring the impact of the hormonal milieu on cognitive functioning. (2009) (0)
- Abstract GS1-07: Results from a phase III randomized, placebo-controlled clinical trial evaluating adjuvant endocrine therapy +/- 1 year of everolimus in patients with high-risk hormone receptor-positive, HER2-negative breast cancer: SWOG S1207 (2023) (0)
- NRG-BR007: A phase III trial evaluating de-escalation of breast radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, hormone receptor+, HER2-, RS ≤18 breast cancer. (2022) (0)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
- Abstract PD5-04: Risk factors for long-term adjuvant chemotherapy toxicity using pre-treatment host factors and self-rated treatment bother (GP5) in a clinical trial population (2022) (0)
- Providing high-quality and affordable intensive care to patients with cancer: The forgotten brick in the steep wall of costs throughout the cancer care continuum. Reply to M. Soares et al. (2014) (0)
- Changes in regional brain metabolism following initial therapy for breast cancer (2011) (0)
- Abstract P5-03-09: Cell composition changes in healthy breast tissue is associated with advancing age and epigenetic age acceleration (2023) (0)
- Simulation study comparing analytical methods for single-item longitudinal patient-reported outcomes data (2022) (0)
- Does extent of breast cancer surgery impact inflammation and fatigue? More is not better (2021) (0)
- Frequency of Symptoms in Women With Breast Cancer (1998) (0)
- Preface to Second Review Issue on Breast Cancer (2008) (0)
- Proximal and distal stress in myeloid cells in women with breast cancer (2017) (0)
- Cumulative burden of severe chronic health conditions (CHC) and health related quality of life (HRQoL) among adult survivors of childhood cancer: A report from the St. Jude Lifetime Cohort study (SJLIFE). (2018) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Abstract 2813: Vitamin D, calcium, and dairy intake and familial breast cancer (2010) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Unintended negative consequences of managing chemotherapy toxicity. (2022) (0)
- Reply to E. Zanet et al. (2014) (0)
- Risk prediction model for heart disease among endometrial cancer survivors. (2018) (0)
- Plans Must Show Quality of Care to Remain Competitive (1996) (0)
- Book Review Textbook of Breast Cancer: A clinical guide to therapy Edited by Gianni Bonadonna, Gabriel N. Hortobagyi, and A. Massimo Gianni. 359 pp., illustrated. St. Louis, Mosby, 1997. $99. 1-85317-348-7 (1998) (0)
- Patient-reported outcomes and behavioral risk factors as predictors of chemoprevention adherence among women in the National Surgical Adjuvant Breast and Bowel Program (NSABP) Breast Cancer Prevention P-1 trial. (2014) (0)
- Title Comparison of Two Multiple Imputation Procedures in a Cancer Screening Survey Permalink (2002) (0)
- Identifying Survivorship Needs Among Women with Breast Cancer after Receiving Radiation Therapy (2018) (0)
- Abstract P1-09-33: Weight loss and bone health in postmenopausal breast cancer survivors (2015) (0)
- The impact of reproductive factors on DNA methylation-based telomere length in healthy breast tissue (2022) (0)
- The Business of Research: Budgets, Personnel, Planning, and Pitfalls—a Report from the American Society of Preventive Oncology's Junior Members Interest Group (2011) (0)
- Addressing Diversity, Equity, and Inclusion at the JNCI Journals. (2022) (0)
- Shared heritability and functional enrichment across six solid cancers (2019) (0)
- Real-world risk-stratified cancer survivorship pathways. (2022) (0)
- Breast cancer and DNA epair gene SNPs in a family cancer registry population (2007) (0)
- Abstract OT1-12-01: A phase III trial evaluating De-escalation of Breast Radiation (DEBRA) following breast-conserving surgery (BCS) of stage 1, HR+, HER2-, RS ≤18 breast cancer: NRG-BR007 (2023) (0)
- Oncologist-reported frequency of managing specific long-term and late effects in breast cancer survivors. (2022) (0)
- Engaging Latino Adolescent and Young Adult (AYA) Cancer Survivors in Their Care: Piloting a Photonovela Intervention (2020) (0)
- 43. Chaotic childhood home environment is associated with heightened inflammatory markers in adult breast cancer survivors (2012) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Abstract ES4-2: Cognitive Changes and Breast Cancer Treatments (2012) (0)
- Integrating Survivorship Care in Oncology: A Conversation with Patricia Ganz, MD (2016) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Younger women are more susceptible to inflammation: A longitudinal examination of the role of aging in inflammation and depressive symptoms. (2022) (0)
- Phase 2 data on a new treatment for hot flushes in women with breast cancer (2022) (0)
- Chapter 22 – The Role of Rehabilitation in the Older Patient with Cancer (2012) (0)
- Longitudinal changes in regional brain metabolism associated with endocrine therapy in prospectively studied breast cancer (BC) patients (2012) (0)
- Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy±everolimusin patients with high-risk, hormone receptor (HR) positive, HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140) (2019) (0)
- Book Review Geriatric Oncology Edited by Lodovico Balducci, Gary H. Lyman, and William B. Ershler. 409 pp., illustrated. Philadelphia, J.B. Lippincott, 1992. $89.50. ISBN 0–397–51210–4 . (1992) (0)
- Regional brain metabolism and peripheral cytokine levels following adjuvant chemotherapy (2010) (0)
- Toxicity Index, patient-reported outcomes, and persistence of breast cancer chemotherapy-associated side effects in NRG Oncology/NSABP B-30 (2022) (0)
- Barriers in providing breast and colorectal cancer survivorship care: Perceptions of U.S. primary care physicians (PCPs) and medical oncologists (MOs). (2011) (0)
- Health S tatus a nd Q uality o f L ife i n P atients W ith Early-Stage H odgkin's D isease T reated o n S outhwest O ncology Group S tudy 9 133 (2003) (0)
- Symptom Scales : A Measure of Physical Symptoms for Women Diagnosed With or at Risk for Breast Cancer (2005) (0)
- Regional brain metabolism and circulating inflammatory cytokines in breast cancer patients after adjuvant chemotherapy (2011) (0)
- Translating Evidence into Practice, Measuring Quality, and Improving Performance (2013) (0)
- Perspectives o n C omorbidity a nd C ancer i n O lder P atients: Approaches t o E xpand t he K nowledge B ase (2001) (0)
- Professional Attitudes Toward Hospice Care (1985) (0)
- Surviv orship: Adult Cancer Surviv ors (2009) (0)
- The Moving Beyond Cancer trial: A psycho educational intervention for women with breast cancer. (2004) (0)
- Flashback Foreword: Estrogen Receptor by Immunohistochemistry in Breast Cancer. (2023) (0)
- Discussing Advances in Chemo Brain Treatment (2019) (0)
- 36. Quality of Life (2014) (0)
- Prediction of treatment (tx)-induced fatigue in breast cancer (BC) patients (pts) using machine learning on genome-wide association (GWAS) data in the prospective CANTO cohort. (2019) (0)
- Neurocognitive performance in breast cancer survivors (BCS): Exploring the relationship with adjuvant treatment, psychological and reproductive factors. (2004) (0)
- University of Groningen Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk Couch, (2013) (0)
- The Evidence Base for High-Quality Cancer Care (2013) (0)
- BRIEF COMMUNICATIONS Agreement Between Breast Cancer Risk Estimation Methods (2005) (0)
- Breast cancer survival rates among Chinese women born in East Asia and the United States (2005) (0)
- Vascular Endothelial Growth Factor Polymorphisms in Early-Stage Non- Small-Cell Lung Cancer (2008) (0)
- Cancer risk, EGD biopsy workload & reporting in a VA Barrett's cohort (2001) (0)
- OP-JNCI190107 1241..1242 (2019) (0)
- Mitomycin c 1 2 chloroethyl 3 cyclohexyl 1 nitroso urea treatment of extensive non small cell carcinoma of the lung (1981) (0)
- HMO organizational structure and colorectal cancer (CRC) screening practices (2001) (0)
- Relationships between neuropsychological function and brain activity following adjuvant chemotherapy (2010) (0)
- Patient-Reported Outcomes (2020) (0)
- Assessing the risk of severe post-treatment (tx) cancer-related fatigue (CRF) among breast cancer survivors (BCS) in the CANcer TOxicity (CANTO) cohort. (2021) (0)
- Abstract P1-09-08: Hormonal factors associated with elevation of DNA methylation age in breast tissue of healthy women (2019) (0)
- Mental health symptom severity and health care utilization in adolescent and young adult cancer survivors. (2022) (0)
- Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis. (2019) (0)
- Helicobacter pylori and nonulcer dyspepsia. (1999) (0)
- New Book on Health Services for Cancer Survivors (2011) (0)
- Breast Cancer Rehabilitation and Survivorship: Cost, Quality, and Lessons Learned (2008) (0)
- 59 INVITED Cancer survivorship: a new challenge in delivering quality cancer care (2007) (0)
- Title Early dissemination of bevacizumab for advanced colorectal cancer : a prospective cohort study Permalink (2011) (0)
- Breast C ancer i n O lder W omen: Q uality o f L ife a nd Psychosocial A djustment i n t he 1 5 M onths A fter D iagnosis (2003) (0)
- The C ase I dentification C hallenge i n M easuring Q uality o f Cancer C are (2002) (0)
- Inflammation and depressive symptoms: A longitudinal examination of the role of aging in women undergoing treatment for breast cancer (2021) (0)
- Objective neuropsychologic performance is associated with levels of medial frontal, temporal, cerebellar activity in brains of breast cancer patients soon after adjuvant chemotherapy (2011) (0)
- Cardiovascular late effects among endometrial cancer survivors in a cohort study. (2017) (0)
- Disparities in the survivorship experience among Latina breast cancer survivors (2017) (0)
- BDNF Met allele as a risk factor for inflammation-induced depression in breast cancer survivors (2015) (0)
- Cancer treatment and behavioral symptoms: Links to aging biology (2017) (0)
- Prevalence, Predictors, and Patient Outcomes Associated with Physician Co-Management (2012) (0)
- A Prospective Longitudinal Cohort Study of Brain Metabolism before and during Endocrine Therapy for Breast Cancer: Relationships to Changes in Learning and Memory, Aromatase Inhibition and Tamoxifen (2018) (0)
- Visualizing adverse events using correspondence analysis (2021) (0)
- Genitourinary disease risks among 5-year ovarian cancer survivors in a population-based cohort study. (2017) (0)
- Ethical Issues in Public Health (1998) (0)
- Lower heart rate variability is associated with cancer-related fatigue in breast cancer survivors (2012) (0)
- Abstract GS4-09: Quality of life results from OlympiA: A phase III, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)-adjuvant chemotherapy in patients with germline BRCA1/2 mutations and high-risk HER-2 negative early breast cancer (2022) (0)
- Assessment of the feasibility of a rehabilitation intervention program for breast cancer survivors with cognitive complaints (2013) (0)
- Comparison of self-reported outcomes with arm functional measurements in early breast cancer patients undergoing nodal biopsy in NSABP Protocol B-32 (2005) (0)
- Impact of Breast Cancer Treatments on Gonadal Function and Reproductive Health (1999) (0)
- Presenting Patient-Reported Outcomes Data to Improve Patient and Clinician Understanding and Use (2018) (0)
- Impact of Cancer Instrument (2019) (0)
- Physical activity (PA) and patterns of quality of life (QOL) after adjuvant chemotherapy (CT) for breast cancer (BC). (2018) (0)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
- Quality of life and symptoms in long-term survivors (LTS) of colorectal cancer (CRC): Results from NSABP protocol LTS-01. (2010) (0)
- Decisions about cancer treatment: Matching of actual to preferred roles and patient ratings of care. (2014) (0)
- Abstract ED02-01: Prevention of cancer in patients and survivors: Epidemiology of survivorship, late effects burden, setting the stage (2011) (0)
- and evaluation of effective strategies to improve the quality of can- cer care. (2014) (0)
- Genetic Counseling for Hereditary Cancer Predisposition Testing (2004) (0)
- Changes in biomarkers and DNA methylation in breast cancer survivors enrolled in the ENERGY weight loss trial: A pilot study. (2016) (0)
This paper list is powered by the following services:
Other Resources About Patricia A. Ganz
What Schools Are Affiliated With Patricia A. Ganz?
Patricia A. Ganz is affiliated with the following schools:
- Medical University of Vienna
- Indiana University
- MD Anderson Cancer Center
- University of Alberta
- University of Michigan
- University of California, Los Angeles
- McGill University
- Indiana University Bloomington
- Ohio State University
- University of British Columbia
- Georgetown University
- University of Pittsburgh
- University of Cambridge
- Harvard University
